Will The Magnificent 7 Stocks Go Up This Year?
2025 was another banner year for the Magnificent Seven stocks,…
Sell
21
HKPD Quote, Financials, Valuation and Earnings
Last price:
$0.77
Seasonality move
:
--
Day range:
$0.75 - $0.83
52-week range:
$0.68 - $3.79
Dividend yield:
0%
P/E ratio:
8.18x
P/S ratio:
0.75x
P/B ratio:
2.30x
Volume:
24.1K
Avg. volume:
117.9K
1-year change:
--
Market cap:
$8.5M
Revenue:
$16.7M
EPS (TTM):
--
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Cellyan Biotechnology Ltd. has -- downside to fair value with a price target of -- per share.
HKPD vs. S&P 500
-
Over the past 5 trading days, Cellyan Biotechnology Ltd. has underperformed the S&P 500 by -5.42% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Cellyan Biotechnology Ltd. does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Cellyan Biotechnology Ltd. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Cellyan Biotechnology Ltd. reported revenues of --.
Earnings Growth
-
Cellyan Biotechnology Ltd. has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Cellyan Biotechnology Ltd. reported earnings per share of --.
Enterprise value:
13.2M
EV / Invested capital:
--
Price / LTM sales:
0.75x
EV / EBIT:
7.08x
EV / Revenue:
0.79x
PEG ratio (5yr expected):
--
EV / Free cash flow:
50.24x
Price / Operating cash flow:
47.58x
Enterprise value / EBITDA:
5.08x
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2024-01-10 | 2025-01-10 | 2025-01-10 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | -- | -- | $8.9M | |
| Total Assets | -- | -- | -- | -- | $10.2M | |
| Current Liabilities | -- | -- | -- | -- | $3.6M | |
| Total Liabilities | -- | -- | -- | -- | $4.8M | |
| Total Equity | -- | -- | -- | -- | $5.4M | |
| Total Debt | -- | -- | -- | -- | $1.2M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2024-01-10 | 2025-01-10 | 2025-01-10 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
HKPD
Sector
Market Cap
$8.5M
--
Price % of 52-Week High
20.45%
--
Dividend Yield
0%
--
Shareholder Yield
--
--
1-Year Price Total Return
--
--
Beta (5-Year)
--
--
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$0.81
200-day SMA
Sell
Level
$1.19
Bollinger Bands (100)
Sell
Level
0.88 - 1.4
Chaikin Money Flow
Sell
Level
-393.8K
20-day SMA
Buy
Level
$0.77
Relative Strength Index (RSI14)
Sell
Level
42.16
ADX Line
Buy
Level
14.6
Williams %R
Neutral
Level
-56.7985
50-day SMA
Sell
Level
$0.97
MACD (12, 26)
Sell
Level
-0.03
25-day Aroon Oscillator
Buy
Level
44
On Balance Volume
Sell
Level
-3.2M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
--
Momentum Score
Level (--)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Cellyan Biotechnology Ltd. engages in providing pharmaceutical cross-border e-commerce supply chain services. It focuses on cross-border pharmaceutical warehousing, cross-border OTC registration and import, and OTC product wholesale services. The company was founded by Lap Sun Wong on August 17, 2023 and is headquartered in Hong Kong.
Stock Forecast FAQ
In the current month, HKPD has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The HKPD average analyst price target in the past 3 months is --.
-
Where Will Cellyan Biotechnology Ltd. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Cellyan Biotechnology Ltd. share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Cellyan Biotechnology Ltd.?
Analysts are divided on their view about Cellyan Biotechnology Ltd. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Cellyan Biotechnology Ltd. is a Sell and believe this share price will rise from its current level to --.
-
What Is Cellyan Biotechnology Ltd.'s Price Target?
The price target for Cellyan Biotechnology Ltd. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is HKPD A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Cellyan Biotechnology Ltd. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of HKPD?
You can purchase shares of Cellyan Biotechnology Ltd. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Cellyan Biotechnology Ltd. shares.
-
What Is The Cellyan Biotechnology Ltd. Share Price Today?
Cellyan Biotechnology Ltd. was last trading at $0.77 per share. This represents the most recent stock quote for Cellyan Biotechnology Ltd.. Yesterday, Cellyan Biotechnology Ltd. closed at $0.78 per share.
-
How To Buy Cellyan Biotechnology Ltd. Stock Online?
In order to purchase Cellyan Biotechnology Ltd. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get HKPD Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
HKPD
Sector
P/E ratio
8.18x
--
PEG ratio
--
--
P/B ratio
2.30x
--
Price / LTM sales
0.75x
--
Growth Metrics
HKPD
Sector
Revenue growth
--
--
Earnings growth
--
--
Revenue (5-year growth)
--
--
Earnings forecast
--
--
Profitability
HKPD
Sector
Profitability FY 2023
$3.6M
--
Return on invested capital
--
--
Return on assets
--
--
Return on equity
--
--
Earnings Date
Last Earnings Date
Jan
10
Next Earnings Date
Jan
10
Estimated Next Earnings Date
Apr
11
Balance Sheet
HKPD
Sector
Total cash
--
--
Short term investments
--
--
Total assets
$8.7M
--
Long term debt
--
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Planet Labs Stock Rally So Much?
Satellite imaging startup Planet Labs (NYSE:PL), after years of disappointing…
Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
65
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Buy
51
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
100
ATGL alert for Jan 10
Alpha Technology Group Ltd. [ATGL] is up 47.05% over the past day.
Buy
71
NAIL alert for Jan 10
Direxion Daily Homebuilders & Supplies Bull 3X Shs [NAIL] is up 18.52% over the past day.
Buy
54
LGIH alert for Jan 10
LGI Homes, Inc. [LGIH] is up 13.81% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
